Table 7 The effect of interventions on serum glucose concentrations
Length of follow-up | p* | p† | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 15 min | 30 min | 45 min | 60 min | 75 min | 90 min | 105 min | 120 min | |||
Glucose, mg/dL | |||||||||||
Group 1 | 72.3 (65.2–79.4) | 88.6 (81.5–95.7) | 88.6 (81.5–95.7) | 70.9 (63.9–78.1) | 74.6 (67.5–81.7) | 77.2 (70.1–84.3) | 78.0 (70.9–85.1) | 77.2 (70.1–84.3) | 75.5 (68.4–82.6) | <0.001 | <0.001 |
Group 2 | 75.2 (68.1–82.3) | 84.8 (77.7–91.9) | 79.4 (72.3–86.5) | 75.8 (68.7–82.9) | 75.6 (68.5–82.7) | 77.0 (69.9–84.1) | 79.5 (72.4–86.6) | 78.9 (71.8–86.0) | 82.3 (75.2–89.4) | ||
Group 3 | 87.5 (80.4–94.6) | 116.9 (109.8–124.0) | 128.9 (121.8–136.0) | 126.1 (118.9–133.2) | 121.3 (114.2–128.4) | 114.5 (107.4–121.6) | 112.2 (105.1–119.3) | 107.1 (99.9–114.2) | 100.5 (93.4–107.6) | ||
Group 4 | 88.8 (81.7–95.9) | 99.1 (91.9–106.2) | 103.7 (96.6–110.8) | 104.0 (96.9–111.1) | 103.1 (95.9–110.2) | 101.3 (94.2–108.4) | 99.4 (92.3–106.5) | 97.5 (90.4–104.6) | 95.5 (88.4–102.6) | ||
p‡ | 0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.02 |